Mild behavioral impairment is a neurobehavioral symptom characterized by the onset of a new and persistent neuropsychiatric syndrome. Patients with co-occurring mild behavioral impairment and mild cognitive impairment have the relatively highest probability of developing dementia than sick mild behavioral impairment or mild cognitive impairment alone.
Objective
This study aimed to determine the currently available best estimate of mild behavioral impairment prevalence and clarify the reasons for the difference in estimates.
Methods
Data were retrieved and collected from five electronic databases. Two reviewers independently appraised the methodological quality of included studies. Heterogeneity was assessed by using the I² statistic and random effects models were employed. Sources of heterogeneity were investigated by subgroup analysis and meta-regression. All statistical analyses were conducted by Stata.
Results
A total of 23 reports involving 5397 participants were included in this systematic review. The pooled effect size for the overall mild behavioral impairment was 52% (95%CI 42-62%). In the subgroup analysis and regression analysis, we found that study type, study area, assessment tools, and study subject gender could explain part of the source of heterogeneity.
Conclusions
The results of this review suggest that 52% with mild cognitive impairment combined with mild behavioral impairment; there is a close relationship between the two. Future studies should pay more attention to the underlying mechanism between the two and provide a more scientific basis for early discrimination of clinical dementia and Alzheimer's disease.
IsmailZSmithEEGedaY, et al.Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement2016; 12: 195–202.
2.
TaraganoFEAllegriRFKrupitzkiH, et al.Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. J Clin Psychiatry2009; 70: 584–592.
3.
MortbyMEBurnsREramudugollaR, et al.Neuropsychiatric symptoms and cognitive impairment: understanding the importance of co-morbid symptoms. J Alzheimers Dis2017; 59: 141–153.
4.
WiseEARosenbergPBLyketsosCG, et al.Time course of neuropsychiatric symptoms and cognitive diagnosis in national Alzheimer’s coordinating centers volunteers. Alzheimers Dement (Amst)2019; 11: 333–339.
5.
Van der MusseleSMariënPSaerensJ, et al.Behavioral syndromes in mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis2014; 38: 319–329.
6.
PinkAStokinGBBartleyMM, et al.Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based study. Neurology2015; 84: 935–943.
7.
ForresterSNGalloJJSmithGS, et al.Patterns of neuropsychiatric symptoms in mild cognitive impairment and risk of dementia. Am J Geriatr Psychiatry2016; 24: 117–125.
8.
PetersMERosenbergPBSteinbergM, et al.Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the cache county study. Am J Geriatr Psychiatry2013; 21: 1116–1124.
9.
RosenbergPBMielkeMMApplebyBS, et al.The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry2013; 21: 685–695.
10.
PetersenRCStevensJCGanguliM, et al.Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). report of the quality standards subcommittee of the American academy of neurology. Neurology2001; 56: 1133–1142.
11.
GedaYERobertsROMielkeMM, et al.Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study. Am J Psychiatry2014; 171: 572–581.
12.
TaraganoFEAllegriRFHeiseckeSL, et al.Risk of conversion to dementia in a mild behavioral impairment group compared to a psychiatric group and to a mild cognitive impairment group. J Alzheimers Dis2018; 62: 227–238.
13.
PetersenRCDoodyRKurzA, et al.Current concepts in mild cognitive impairment. Arch Neurol2001; 58: 1985–1992.
14.
TengELuPHCummingsJL. Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer’s disease. Dement Geriatr Cogn Disord2007; 24: 253–259.
15.
PageMJMcKenzieJEBossuytPM, et al.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ2021; 372: 71.
16.
StroupDFBerlinJAMortonSC, et al.Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA2000; 283: 2008–2012.
17.
HoyDBrooksPWoolfA, et al.Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol2012; 65: 934–939.
18.
BarendregtJJDoiSALeeYY, et al.Meta-analysis of prevalence. J Epidemiol Community Health2013; 67: 974–978.
19.
HigginsJPThompsonSGDeeksJJ, et al.Measuring inconsistency in meta-analyses. BMJ2003; 327: 557–560.
20.
SheikhFIsmailZMortbyME, et al.Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden. Int Psychogeriatr2018; 30: 233–244.
21.
MortbyMEIsmailZAnsteyKJ. Prevalence estimates of mild behavioral impairment in a population-based sample of pre-dementia states and cognitively healthy older adults. Int Psychogeriatr2018; 30: 221–232.
22.
MalloSCIsmailZPereiroAX, et al.Assessing mild behavioral impairment with the mild behavioral impairment-checklist in people with mild cognitive impairment. J Alzheimers Dis2018; 66: 83–95.
23.
MatsuokaTIsmailZNarumotoJ. Prevalence of mild behavioral impairment and risk of dementia in a psychiatric outpatient clinic. J Alzheimers Dis2019; 70: 505–513.
24.
YokoiYTakanoHSakataM, et al.Discrete effect of each mild behavioural impairment category on dementia conversion or cognitive decline in patients with mild cognitive impairment. Psychogeriatrics2019; 19: 591–600.
25.
NaudeJPGillSHuS, et al.Plasma neurofilament light: a marker of neurodegeneration in mild behavioral impairment. J Alzheimers Dis2020; 76: 1017–1027.
26.
SooSANgKPWongF, et al.The association between diabetes mellitus and mild behavioral impairment among mild cognitive impairment: findings from Singapore. J Alzheimers Dis2021; 82: 411–420.
27.
KianimehrGFatehiFNoroozianM. Prevalence of mild behavioral impairment in patients with mild cognitive impairment. Acta Neurol Belg2022; 122: 1493–1497.
28.
GhahremaniMNathanSSmithEE, et al.Functional connectivity and mild behavioral impairment in dementia-free elderly. Alzheimers Dement (N Y)2023; 9: e12371.
29.
RouseHJSmallBJSchinkaJA, et al.Mild behavioral impairment as a predictor of cognitive functioning in older adults. Int Psychogeriatr2021; 33: 285–293.
30.
SunYXuWChenKL, et al.Mild behavioral impairment correlates of cognitive impairments in older adults without dementia: mediation by amyloid pathology. Transl Psychiatry2021; 11: 577.
31.
ChanDCKasperJDBlackBS, et al.Prevalence and correlates of behavioral and psychiatric symptoms in community-dwelling elders with dementia or mild cognitive impairment: the memory and medical care study. Int J Geriatr Psychiatry2003; 18: 174–182.
32.
BaiyewuOUnverzagtFWOgunniyiA, et al.Behavioral symptoms in community-dwelling elderly Nigerians with dementia, mild cognitive impairment, and normal cognition. Int J Geriatr Psychiatry2012; 27: 931–939.
33.
Fernandez-MartinezMMolanoACastroJ, et al.Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer’s disease, and its relationship with cognitive impairment. Curr Alzheimer Res2010; 7: 517–526.
34.
YatawaraCHiuSTanL, et al.Neuropsychiatric symptoms in South-East Asian patients with mild cognitive impairment and dementia: prevalence, subtypes, and risk factors. Int J Geriatr Psychiatry2018; 33: 122–130. 20170227.
35.
RosenbergPBMielkeMMApplebyB, et al.Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatr Psychiatry2011; 26: 364–372.
36.
Di IulioFPalmerKBlundoC, et al.Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer’s disease and mild cognitive impairment subtypes. Int Psychogeriatr2010; 22: 629–640.
37.
ChanWCLamLCTamCW, et al.Prevalence of neuropsychiatric symptoms in Chinese older persons with mild cognitive impairment-a population-based study. Am J Geriatr Psychiatry2010; 18: 948–954.
38.
RyuSHHaJHParkDH, et al.Persistence of neuropsychiatric symptoms over six months in mild cognitive impairment in community-dwelling Korean elderly. Int Psychogeriatr2011; 23: 214–220.
39.
LyketsosCGLopezOJonesB, et al.Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA2002; 288: 1475–1483.
40.
EllisonJMHarperDGBerlowY, et al.Beyond the “C” in MCI: noncognitive symptoms in amnestic and non-amnestic mild cognitive impairment. CNS Spectr2008; 13: 66–72.
41.
RozziniLVicini ChiloviBContiM, et al.Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Dement Geriatr Cogn Disord2008; 25: 32–36.
42.
HwangTJMastermanDLOrtizF, et al.Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord2004; 18: 17–21.
43.
MortbyMEBlackSEGauthierS, et al.Dementia clinical trial implications of mild behavioral impairment. Int Psychogeriatr2018; 30: 171–175.
44.
AngelopoulouEKorosCHatzimanolisA, et al.Exploring the genetic landscape of mild behavioral impairment as an early marker of cognitive decline: an updated review focusing on Alzheimer’s disease. Int J Mol Sci2024; 25: 20240224.
45.
PanYSheaYFLiS, et al.Prevalence of mild behavioural impairment: a systematic review and meta-analysis. Psychogeriatrics2021; 21: 100–111.
46.
PanYSheaYFIsmailZ, et al.Prevalence of mild behavioural impairment domains: a meta-analysis. Psychogeriatrics2022; 22: 84–98.
47.
LeiRSunYLiaoJ, et al.Sex hormone levels in females of different ages suffering from depression. BMC Womens Health2021; 21: 215. 20210522.
48.
WolfovaKCreeseBAarslandD, et al.Gender/sex differences in the association of mild behavioral impairment with cognitive aging. J Alzheimers Dis2022; 88: 345–355.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
